The tissue diagnostics market plays a crucial role in disease detection and treatment planning, particularly in cancer diagnostics. Valued at USD 6.83 billion in 2023, the market is projected to reach USD 14.18 billion by 2032, growing at a CAGR of 8.47%. Growth is driven by rising cancer prevalence, increasing adoption of personalized medicine, and technological advancements such as digital pathology and AI-based image analysis. Emerging markets and the integration of smart diagnostic tools offer strong future opportunities.